Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PXMD PaxMedica > Detailed Quotes

PXMD PaxMedica

2.520
+0.080+3.28%
Close 10/06 16:00 ET
2.540
+0.020+0.79%
Post Mkt Price 10/06 19:42 ET
High
2.780
Open
2.540
Turnover
2.57M
Low
2.310
Pre Close
2.440
Volume
989.14K
Market Cap
29.68M
P/E(TTM)
5.93
52wk High
10.480
Shares
11.78M
P/E(Static)
Loss
52wk Low
2.040
Float Cap
3.89M
Bid/Ask %
-88.68%
Historical High
10.480
Shs Float
1.55M
Volume Ratio
2.68
Historical Low
2.040
Dividend TTM
--
Div Yield TTM
--
P/B
-3.76
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
64.00%
Amplitude
19.26%
Avg Price
2.598
Lot Size
1
Float Cap
3.89M
Bid/Ask %
-88.68%
Historical High
10.480
Shs Float
1.55M
Volume Ratio
2.68
Historical Low
2.040
Dividend TTM
--
P/B
-3.76
Dividend LFY
--
Turnover Ratio
64.00%
Amplitude
19.26%
Avg Price
2.598
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
PaxMedica, Inc. is an early clinical stage biopharmaceutical company. It focuses on the development of anti-purinergic therapies for the treatment of neurodevelopmental disorders, including autism spectrum disorder and Fragile X syndrome tremor-ataxia. The company was founded in April 5, 2018 and is headquartered in Woodcliff Lake, NJ.
CEO: Mr. Howard J. Weisman
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...